C-Path’s TRxA Announces its First Global Request for Proposals from Academic Investigators Working to Advance Drug Development Projects

Launched in 2022, the Translational Therapeutics Accelerator (TRxA) is a global drug discovery and development program focused on supporting academic scientists in defining optimal strategies for advancing new, cutting-edge therapeutics from the lab to patients. TRxA is now accepting applications for its 2023 funding cycle.Continue reading→

Phoenix-based TapRoot raises $1.4 million Seed Round to Redefine Caregiving for Cognitively Impacted Persons

Phoenix, Arizona. Jan. 16, 2023 — TapRoot Interventions & Solutions, Inc. (“TapRoot”), a Phoenix-based digital healthcare company, closed a $1.4 million dollar seed round in late December. TapRoot’s mission is to improve health outcomes for cognitively challenged persons and their caregivers via TapRoot’s digital solution, Ella®.  Croghan Investments led the round followed by strategic angel investors.Continue reading→